P
Puji Bio
Molecular diagnostic kits for rapid, cost-effective diagnostics
About Puji Bio
Puji Bio, also known as Pregene Biotechnology, is a developer, producer, and seller of molecular diagnostic kits and related supporting instruments. The company focuses on technologies such as ultra-multiplex PCR, droplet generation, advanced nucleic acid extraction, and single-cell sequencing. This enables medical professionals to perform molecular diagnostics in a rapid and cost-effective manner. The firm's primary industry is Diagnostic Equipment, with a focus on Life Sciences and Oncology. As a privately held, venture capital-backed company, Puji Bio secured $15.7 million in an Early Stage VC funding round on January 10, 2022.
The company is located in Nanjing, Jiangsu, China. Its product pipeline is centered on creating accessible diagnostic tools. This includes the development of digital amplification detection methods and kits designed for identifying multiple genotypes simultaneously, for which it has pending patent applications.
Source: Dealroom company dataAt a glance
- Founded
- 2019
- Headquarters
- Nanjing City, China
Knowledge graph
More headlines
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Seed1 investor entered at this stage
Vertex Ventures China
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about Puji Bio on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Puji Bio on the full Dealroom platform
Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.